Cost-benefit analysis of psychological therapy

By R. Layard, D. M. Clark, Martin Knapp, Guy Mayraz. National Institute Economic Review, 2007

229 citations recorded by the source corpus.

Subfields: Clinical Psychology, Pharmacology, Social Psychology

View Paper: https://www.semanticscholar.org/paper/b7535e5b0af2f3fc3b11de34bdf4d40aa9c349c7

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Clinical Psychology

1. David M. Clark
2. Stefan G. Hofmann
3. Mark B. Powers
4. F. Ruiz

In Pharmacology

1. David M. Clark

In Social Psychology

1. David M. Clark
2. Stefan G. Hofmann

Citations in the corpus

• Implementing NICE guidelines for the psychological treatment of depression and anxiety disorders: The IAPT experience (2011, background): “This argument was advanced in academic articles (e.g. Layard et al., 2007), but also in the more populist pamphlets such as The Depression Report (Layard et al., 2006) and We need to Talk (Mind, 2010) (a report sponsored by numerous mental health and other charities).”
• Cognitive Behavioral Therapy for Anxiety and Related Disorders: A Meta-Analysis of Randomized Placebo-Controlled Trials (2018, background): “These disorders are associated with high societal costs (Kessler & Greenberg, 2002; Laynard, Clark,Knapp,&Mayraz, 2007), aswell as significant decrements inpsychosocial functioning and quality of life (QOL; Comer et al., 2011; Hendriks et al., 2016; Olatunji, Cisler, & Tolin, 2007).”